Inflectra savings card: as little as $0 a treatment with commercial insurance

Inflectra is given by a doctor or nurse and billed by the clinic, not a pharmacy. Your care team and your insurance decide which product you get, so ask them what you’d pay.

How to pay the least

Given by your care team

Billed by the clinic

Inflectra is given by a doctor or nurse, not picked up at a pharmacy.

Ask your care team or your plan what you’d pay before your visit.

Compare every option

Brand nameInflectra

Authorized genericinfliximab-dyyb

Regular genericinfliximab-dyyb

What you’d pay

Cash priceAsk the pharmacy

Not soldThere isn’t one

Not soldAsk the pharmacy

Same as Inflectra?

The original

–

Brand nameThe maker’s card

Pfizer enCompass Co-Pay Assistance Program for INFLECTRA

Savings card from Pfizer

No insuranceNeeds insuranceNo cash price listed.

Insurance · as little as $0 a treatment

The card takes up to $2,000–$12,000 a year off your co-pay.

Or call 1-844-722-6672. See the offer on pfizerencompass.com

In the maker’s words

“Eligible enrolled patients may pay as little as $0 for each INFLECTRA treatment…”

From the maker’s offer on pfizerencompass.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Authorized genericNot sold

There isn’t one. An authorized generic is Inflectra itself, from the same company, sold without the brand name, and usually for less. For now Inflectra is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

Inflectra is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

INFLECTRA is a tumor necrosis factor (TNF) blocker indicated for:

Crohn's Disease:

reducing signs and symptoms and inducing and maintaining clinical remission in adult patients with moderately to severely active disease who have had an inadequate response to conventional therapy.
reducing the number of draining enterocutaneous and rectovaginal fistulas and maintaining fistula closure in adult patients with fistulizing disease.

Pediatric Crohn's Disease:

reducing signs and symptoms and inducing and maintaining clinical remission in pediatric patients 6 years of age and older with moderately to severely active disease who have had an inadequate response to conventional therapy.

Ulcerative Colitis:

reducing signs and symptoms, inducing and maintaining clinical remission and mucosal healing, and eliminating corticosteroid use in adult patients with moderately to severely active disease who have had an inadequate response to conventional therapy.

Pediatric Ulcerative Colitis:

reducing signs and symptoms and inducing and maintaining clinical remission in pediatric patients 6 years of age and older with moderately to severely active disease who have had an inadequate response to conventional therapy.

Rheumatoid Arthritis in combination with methotrexate:

reducing signs and symptoms, inhibiting the progression of structural damage, and improving physical function in adult patients with moderately to severely active disease.

Ankylosing Spondylitis:

reducing signs and symptoms in adult patients with active disease.

Psoriatic Arthritis:

reducing signs and symptoms of active arthritis, inhibiting the progression of structural damage, and improving physical function in adult patients.

Plaque Psoriasis:

treatment of adult patients with chronic severe (i.e., extensive and/or disabling) plaque psoriasis who are candidates for systemic therapy and when other systemic therapies are medically less appropriate.

Source: the FDA label for Inflectra (Pfizer Laboratories Div Pfizer Inc), July 28, 2026. Full label on DailyMed

Good to know

“Commercial insurance” means a plan from a job, from the marketplace, or one you buy yourself. A retiree plan that’s part of Medicare counts as Medicare. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.
Most cards need a sign-up on the maker’s site, and many work only if your plan covers the drug. Then give the card’s details to the clinic’s billing office.
Don’t stop or change a medicine without talking to your pharmacist or prescriber.

Prices checked November 2, 2026. Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/inflectra/